Cargando…
Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841439/ https://www.ncbi.nlm.nih.gov/pubmed/27143883 http://dx.doi.org/10.2147/IJN.S100418 |
_version_ | 1782428394965696512 |
---|---|
author | Huang, Pao-Hsien Hu, Stephen Chu-Sung Lee, Chiang-Wen Yeh, An-Chi Tseng, Chih-Hua Yen, Feng-Lin |
author_facet | Huang, Pao-Hsien Hu, Stephen Chu-Sung Lee, Chiang-Wen Yeh, An-Chi Tseng, Chih-Hua Yen, Feng-Lin |
author_sort | Huang, Pao-Hsien |
collection | PubMed |
description | 7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, limits its pharmacological effects when applied topically to the skin. We seek to use the nanoprecipitation method to prepare optimal eudragit E100 (EE)–polyvinyl alcohol (PVA)-loaded 734THIF nanoparticles (734N) to improve its physicochemical properties and thereby increase its water solubility, skin penetration, and biological activities. EE–PVA-loaded 734THIF nanoparticles (734N) were prepared, and their morphology and particle size were evaluated using a particle size analyzer and by electron microscopy. The drug loading and encapsulation efficiencies and in vitro solubility were determined using high-performance liquid chromatography. Hydrogen-bond formation was evaluated by (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and crystalline-to-amorphous transformation was determined by differential scanning calorimetry and X-ray diffractometry. In vitro skin penetration was analyzed using fresh pig skin mounted on Franz diffusion cells, and cytotoxicity against human keratinocyte HaCaT cells was evaluated using the MTT assay. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl-free radical scavenging ability. EE–PVA-loaded 734THIF nanoparticles showed good drug loading and encapsulation efficiencies and were characterized by improved physicochemical properties, including reduction in particle size, amorphous transformation, and intermolecular hydrogen-bond formation. This is associated with increased water solubility and enhanced in vitro skin penetration, with no cytotoxicity toward HaCaT cells. In addition, 734THIF nanoparticles retained their antioxidant activity. In conclusion, 734THIF nanoparticles are characterized by improved physicochemical properties, increased water solubility, and enhanced skin penetration, and these may have potential use in the future as a topical delivery formulation for the treatment of skin diseases. |
format | Online Article Text |
id | pubmed-4841439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48414392016-05-03 Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration Huang, Pao-Hsien Hu, Stephen Chu-Sung Lee, Chiang-Wen Yeh, An-Chi Tseng, Chih-Hua Yen, Feng-Lin Int J Nanomedicine Original Research 7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, limits its pharmacological effects when applied topically to the skin. We seek to use the nanoprecipitation method to prepare optimal eudragit E100 (EE)–polyvinyl alcohol (PVA)-loaded 734THIF nanoparticles (734N) to improve its physicochemical properties and thereby increase its water solubility, skin penetration, and biological activities. EE–PVA-loaded 734THIF nanoparticles (734N) were prepared, and their morphology and particle size were evaluated using a particle size analyzer and by electron microscopy. The drug loading and encapsulation efficiencies and in vitro solubility were determined using high-performance liquid chromatography. Hydrogen-bond formation was evaluated by (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and crystalline-to-amorphous transformation was determined by differential scanning calorimetry and X-ray diffractometry. In vitro skin penetration was analyzed using fresh pig skin mounted on Franz diffusion cells, and cytotoxicity against human keratinocyte HaCaT cells was evaluated using the MTT assay. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl-free radical scavenging ability. EE–PVA-loaded 734THIF nanoparticles showed good drug loading and encapsulation efficiencies and were characterized by improved physicochemical properties, including reduction in particle size, amorphous transformation, and intermolecular hydrogen-bond formation. This is associated with increased water solubility and enhanced in vitro skin penetration, with no cytotoxicity toward HaCaT cells. In addition, 734THIF nanoparticles retained their antioxidant activity. In conclusion, 734THIF nanoparticles are characterized by improved physicochemical properties, increased water solubility, and enhanced skin penetration, and these may have potential use in the future as a topical delivery formulation for the treatment of skin diseases. Dove Medical Press 2016-04-18 /pmc/articles/PMC4841439/ /pubmed/27143883 http://dx.doi.org/10.2147/IJN.S100418 Text en © 2016 Huang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Huang, Pao-Hsien Hu, Stephen Chu-Sung Lee, Chiang-Wen Yeh, An-Chi Tseng, Chih-Hua Yen, Feng-Lin Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title | Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title_full | Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title_fullStr | Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title_full_unstemmed | Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title_short | Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
title_sort | design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841439/ https://www.ncbi.nlm.nih.gov/pubmed/27143883 http://dx.doi.org/10.2147/IJN.S100418 |
work_keys_str_mv | AT huangpaohsien designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration AT hustephenchusung designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration AT leechiangwen designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration AT yehanchi designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration AT tsengchihhua designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration AT yenfenglin designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration |